-
公开(公告)号：US20190077826A1
公开(公告)日：2019-03-14
申请号：US16184399
申请日：2018-11-08
发明人： Cheng-Gang LIN , Li GUI , Pan CHEN , Zhi-Xuan WANG , Tong-Wei GUAN , Yuan-Yuan YIN , Yu-Ling LU
摘要： The present invention discloses method for preparing deoxycholic acid (DCA) or an ester thereof or a pharmaceutically acceptable salt thereof. Said compounds may be applied to remove a fat deposition.
-
公开(公告)号：US20180111960A1
公开(公告)日：2018-04-26
申请号：US15566097
申请日：2016-02-26
发明人： Cheng-Gang LIN , Li GUI , Pan CHEN , Zhi-Xuan WANG , Tong-Wei GUAN , Yuan-Yuan YIN , Yu-Ling LU
CPC分类号： C07J9/005 , C07J1/0011 , C07J13/007 , C07J21/008
摘要： The present invention discloses method for preparing deoxycholic acid (DCA) or an ester thereof or a pharmaceutically acceptable salt thereof. Said compounds may be applied to remove a fat deposition.
-
公开(公告)号：US20200071293A1
公开(公告)日：2020-03-05
申请号：US15999610
申请日：2016-02-19
发明人： Yun-Zhe SUN , Wei-Ming JIANG , Xin ZHAO , Cheng-Gang LIN , Li GUI , Fei LUI
IPC分类号： C07D401/12 , A61P25/00
摘要： The present invention relates to a crystalline form N of aripiprazole, pharmaceutical compositions thereof and the use of crystalline form N in the preparation of a medicament for the treatment of central nervous system diseases, especially schizophrenia.
-
公开(公告)号：US20190070171A1
公开(公告)日：2019-03-07
申请号：US15755801
申请日：2016-03-16
发明人： Yunzhe SUN , Qi PENG , Cheng-Gang LIN , Li GUI , Zhihui LIU , Fei LIU
IPC分类号： A61K31/496 , A61K9/00 , A61K9/10 , A61K47/38 , A61K47/26
摘要： The present invention belongs to the field of pharmaceutical formulation, and particularly relates to an aripiprazole injectable suspension formulation having prolonged shelf life, and methods of using the formulation in treating schizophrenia and related diseases. In another aspect, the present invention also relates to a method of prolonging shelf life of an aripiprazole injectable suspension formulation.
-
-
-
搜索结果
4 条记录 (耗时 0.013 秒)
